Evidence map›Paper›PMID 41056040›Full record

ArticleInternational journal of surgery (London, England)2026

Deep learning for prognostic stratification and biomarker exploration in upper tract urothelial carcinoma: a multicenter retrospective cohort study.

Xiang Peng, Hao Tan, Bangxin Xiao, Yiwen Tan, Xiaofeng Yue, Youde Cao, Bing Liang, Wenlong Zhao, Yingjia Liu, Quanhao He and 2 more

Abstract readMulticenter Study
In one paragraph

Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiang PengDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Hao TanDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Bangxin XiaoDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Yiwen TanDepartment of Pathology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Xiaofeng YueDepartment of Urology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Youde CaoDepartment of Pathology, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Bing LiangDepartment of Pathology, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Wenlong ZhaoCollege of Medical Informatics, Chongqing Medical University, Chongqing, People's Republic of China.
Yingjia LiuDepartment of Pathology, Yongchuan Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Quanhao HeDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Weiyang HeDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Mingzhao XiaoDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.ORCID 0000-0001-6989-5971

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUpper tract urothelial carcinoma (UTUC) necessitates precise prognostic assessment for personalized therapy due to its aggressive nature and the limitations of traditional methods. An objective, interpretable pathological evaluation system is urgently needed to improve UTUC risk stratification and patient outcomes.

methodsIn this multicenter retrospective study, we developed a prior knowledge-guided deep learning system using whole-slide images from 805 UTUC patients who underwent radical nephroureterectomy. The UCSegNet tile classifier was employed for eight-category tissue segmentation, and the CONCH vision-language model was used for tumor patch categorization, creating integrated probability heatmaps. Two prognostic networks, MacroContextNet and PGCA-Net, were then trained to predict the overall survival (OS) by integrating these multiscale pathological features. AI-derived quantitative pathological biomarkers were explored, including tissue fraction scores and co-localization scores. Model performance was evaluated using the concordance index (C-index), time-dependent area under the receiver operating characteristic curve (AUC), and multivariable Cox regression.

resultsThe UCSegNet tile classifier achieved excellent multiclass tissue classification accuracy across all cohorts (AUC range: 0.9916-0.9948). The primary prognostic model, PGCA-Net, demonstrated superior prognostic performance (C-index range: 0.672-0.795 across validation cohorts) compared to MacroContextNet (C-index range: 0.643-0.730) and outperformed current state-of-the-art models. After adjustment for clinical covariates, PGCA-Net effectively stratified patients into high-risk and low-risk groups for OS, with hazard ratios (HRs) for the high-risk group ranging from 4.93 to 9.38 across different cohorts. Seven AI-derived quantitative pathological biomarkers were identified and validated; notably, high tumor-muscle co-localization (Coloc_M) scores (HR up to 5.06) and high tumor-renal parenchyma co-localization (Coloc_R) scores (HR up to 4.52) consistently predicted increased mortality risk.

conclusionsThis prior knowledge-guided deep learning system significantly improves OS prediction and risk stratification in UTUC by integrating multiscale pathological features. The AI-driven, interpretable tool offers an objective approach for prognostic assessment and biomarker discovery, with strong potential to refine personalized UTUC management and enhance prognostic accuracy.

Indexed as

Carcinoma, Transitional CellDeep LearningKidney NeoplasmsUrologic NeoplasmsAgedAged, 80 and overBiomarkers, TumorFemaleHumansMaleMiddle AgedNephroureterectomyPrognosisRetrospective StudiesRisk AssessmentBiomarkers, Tumorartificial intelligence biomarkersprognostic prediction systemupper tract urothelial carcinoma

Identifiers

PMID41056040
PMCPMC12825564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.